BDBM293990 (2S)-5-(2-(4-((3-(1-Methyl-1H- pyrazol-5-yl)benzo[b]thiophen- 5-yl)methoxy)phenyl)pent-3-yn- 1-yl)-1H-tetrazole::US10106553, Compound 22

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(-c4ccnn4C)c3c2)cc1

InChI Key InChIKey=MVWZPDWVBDIQQU-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 293990   

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293990(US10106553, Compound 22 | (2S)-5-(2-(4-((3-(1-Meth...)
Affinity DataEC50:  67nMT: 2°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

LigandPNGBDBM293990(US10106553, Compound 22 | (2S)-5-(2-(4-((3-(1-Meth...)
Affinity DataEC50:  32nMAssay Description:Agonist activity at rat GPR40 assessed as increase in intracellular calcium flux by cell based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293990(US10106553, Compound 22 | (2S)-5-(2-(4-((3-(1-Meth...)
Affinity DataEC50:  67nMAssay Description:Agonist activity at human GPR40 assessed as increase in intracellular calcium flux by cell based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed